New diabetes clinical trial: A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
- Get link
- X
- Other Apps
Published on: October 28, 2020 at 09:30PM
Condition: Type 2 Diabetes
Interventions: Drug: LY900014; Drug: Insulin Glargine
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3jEFEJo
Condition: Type 2 Diabetes
Interventions: Drug: LY900014; Drug: Insulin Glargine
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3jEFEJo
Comments
Post a Comment